Search
Back 

2019 Announcements

2019 Announcements


July 24, 2019
NRG Oncology is seeking an experienced Patient Advocate to serve as Chair for its Patient Advocate Committee Read more

July 1, 2019 UPDATED
Independence Day Holiday Closures for Operations, SDMCs, Biospecimen Banks, Serum Bank, and McKesson Clinical Research Services. Read more

May 20, 2019
Memorial Day closures for Operations, SDMCs, Biospecimen Banks, Serum Bank, and McKesson Clinical Research Services. Read more

May 3, 2019
Patient Reported Outcomes: Upping the game for PRO methods and design in clinical trials

NRG Oncology will be holding a workshop at the NRG Semiannual Meeting related to improving statistical methods to meet study goals, analyzing longitudinal PRO data as well as a panel discussion with NCORP PIs. This session will be held on Thursday, July 18, 2019 from 1-5 pm ET and will be open to all attendees. More information on the session and agenda will be released soon.

April 23, 2019
Project Team Member Application – Abemaciclib 

Applicants, please submit the form to the NRG protocol development office by COB Monday, May 6, 2019. NRG Oncology will submit the application to CTEP by the deadline of May 13, 2019.


April 17, 2019

NRG Oncology SDMC Awarded NCI Funding for Next 6 Years with ‘Outstanding’ Score

The NRG Oncology Statistics and Data Management Center (SDMC) was notified that the center will be awarded six more years of funding from the National Cancer Institute (NCI) and will continue to serve the NCI National Clinical Trials Network (NCTN) group NRG Oncology. The total amount of funding requested for the six year effort was $68.9 million. During the peer review grant renewal process, the NRG Oncology SDMC was ranked within the “Outstanding” range with a score of 18. Read more

April 16, 2019 

NRG Oncology Awarded NCI Funding for Next 6 Years, Receives "Exceptional" Score

NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group conducting practice-changing clinical and translational research, has been awarded funding of $16.5 Million by the NCI for the next six years to continue its work as a lead protocol organization (LPO) program. During the peer review grant renewal process, NRG Oncology received the “exceptional” score of 16. Read more

March 5, 2019
Project Team Member Application – BAY 1895344

Applicants, please submit the form to the NRG protocol development office by COB Tuesday, March 19, 2019. NRG Oncology will submit the application to CTEP by the deadline of March 26, 2019.

February 21, 2019
NRG Oncology NCORP Pilot Projects
NRG Oncology NCORP is soliciting PILOT projects for applications focused on NRG NCORP Cancer Prevention and Control (CPC) priorities that will provide data that will directly lead to future Phase II-III CPC concepts. As put forward in our core grant, CPC priorities for funding include cancer prevention research and cancer control investigation aimed at understanding and/or ameliorating the symptoms and toxicity related to:

  • Neurocognitive function
  • Gender specific symptom reduction
  • Behavioral interventions
  • Treatment dose alterations or delivery
  • Cancer risk reduction
  • Chemotherapy induced peripheral neuropathy 


For full details read more

NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Cancer Care Delivery Research (CCDR) priorities. CCDR funding priorities are:

  • Implementation and dissemination interventions related to guideline based care:
    • Use of tumor DNA sequencing prior to prescribing targeted therapies(<1/4 of CCDR practices report routine use);
    • Integrating patient-reported outcomes into clinical practice (extends survival);
    • Enhance access to proven survivorship and palliative care strategies optimizing survivor and family quality of life; 
    • Optimize screening strategies based on disease risk including patients in the post-treatment surveillance phase of care; and 
    • Implement evidence-based symptom management strategies addressing patients’ needs during both active adjuvant and palliative treatment.
  • Patient-reported outcomes (PROs) related to symptom management:  The CCDR committee will prioritize proposals including the PRO-CTCAE in NRG NCORP trials, and improve compliance and data capture. The CCDR committee also encourages studies employing technology or apps to standardized PRO variables across EHR, registry, and claims data systems. 

For full details read more

NRG Oncology Strategic Planning Debrief
NRG Oncology makes plans for its continued success as leaders and stakeholders across the organization gathered December 14-15, 2018 to explore potential focus areas and goals for the organization.

Open the Special Report broadcast
Printable version



Martin Luther King Jr Holiday Closures
MLK Day closures for NRG Oncology offices and banks. Read more

Copyright 2019 by NRG Oncology